Increased need for thyroxine in women with hypothyroidism during estrogen therapy
- PMID: 11396440
- DOI: 10.1056/NEJM200106073442302
Increased need for thyroxine in women with hypothyroidism during estrogen therapy
Abstract
Background: Women with hypothyroidism that is being treated with thyroxine often need higher doses when they are pregnant. Whether this need can be attributed solely to estrogen-induced increases in serum thyroxine-binding globulin or whether other factors are involved is not known.
Methods: In 11 postmenopausal women with normal thyroid function and 25 postmenopausal women with hypothyroidism treated with thyroxine, I assessed thyroid function before they started estrogen therapy and every 6 weeks for 48 weeks thereafter. The women with hypothyroidism included 18 women receiving thyroxine-replacement therapy and 7 women receiving thyrotropin-suppressive thyroxine therapy. On each occasion, serum thyroxine, free thyroxine, thyrotropin, and thyroxine-binding globulin were measured.
Results: In the women with normal thyroid function, the serum free thyroxine and thyrotropin concentrations did not change, whereas at 12 weeks the mean (+/-SD) serum thyroxine concentration had increased from 8.0+/-0.9 microg per deciliter (103+/-12 nmol per liter) to 10.4+/-1.5 microg per deciliter (134+/-19 nmol per liter, P<0.001) and the serum thyroxine-binding globulin concentration had increased from 20.3+/-3.5 mg per liter to 31.3+/-3.2 mg per liter, P<0.001). The women with hypothyroidism had similar increases in serum thyroxine and thyroxine-binding globulin concentrations during estrogen therapy, but their serum free thyroxine concentration decreased from 1.7+/-0.4 ng per deciliter (22+/-5 pmol per liter) to 1.4+/-0.3 ng per deciliter (18+/-4 pmol per liter, P<0.001) and their serum thyrotropin concentration increased from 0.9+/-1.1 to 3.2+/-3.1 microU per milliliter (P<0.001). The serum thyrotropin concentrations increased to more than 7 microU per milliliter in 7 of the 18 women in the thyroxine-replacement group and to more than 1 microU per milliliter in 3 of the 7 women in the thyrotropin-suppression group.
Conclusions: In women with hypothyroidism treated with thyroxine, estrogen therapy may increase the need for thyroxine.
Comment in
-
Estrogen, thyroxine binding in serum, and thyroxine therapy.N Engl J Med. 2001 Jun 7;344(23):1784-5. doi: 10.1056/NEJM200106073442310. N Engl J Med. 2001. PMID: 11396448 No abstract available.
Similar articles
-
Increased need for thyroxine during pregnancy in women with primary hypothyroidism.N Engl J Med. 1990 Jul 12;323(2):91-6. doi: 10.1056/NEJM199007123230204. N Engl J Med. 1990. PMID: 2359428
-
Estrogen, thyroxine binding in serum, and thyroxine therapy.N Engl J Med. 2001 Jun 7;344(23):1784-5. doi: 10.1056/NEJM200106073442310. N Engl J Med. 2001. PMID: 11396448 No abstract available.
-
Impaired action of thyroid hormone associated with smoking in women with hypothyroidism.N Engl J Med. 1995 Oct 12;333(15):964-9. doi: 10.1056/NEJM199510123331503. N Engl J Med. 1995. PMID: 7666915
-
Thyroid function and postmenopause.Gynecol Endocrinol. 2003 Feb;17(1):79-85. Gynecol Endocrinol. 2003. PMID: 12724022 Review.
-
Thyroxine therapy.N Engl J Med. 1994 Jul 21;331(3):174-80. doi: 10.1056/NEJM199407213310307. N Engl J Med. 1994. PMID: 8008032 Review.
Cited by
-
Analysis of factors influencing the dose of levothyroxine treatment in adequately controlled hypothyroid patients of different etiologies.Heliyon. 2024 Oct 19;10(20):e39639. doi: 10.1016/j.heliyon.2024.e39639. eCollection 2024 Oct 30. Heliyon. 2024. PMID: 39502224 Free PMC article.
-
Medications and Food Interfering with the Bioavailability of Levothyroxine: A Systematic Review.Ther Clin Risk Manag. 2023 Jun 23;19:503-523. doi: 10.2147/TCRM.S414460. eCollection 2023. Ther Clin Risk Manag. 2023. PMID: 37384019 Free PMC article. Review.
-
The Thyroid Hormone Axis and Female Reproduction.Int J Mol Sci. 2023 Jun 6;24(12):9815. doi: 10.3390/ijms24129815. Int J Mol Sci. 2023. PMID: 37372963 Free PMC article. Review.
-
Effects of varying doses of conjugated estrogen on body weight, hormonal and histological alterations of reproductive organs in adult swiss albino female mice.Heliyon. 2023 Apr 1;9(4):e15112. doi: 10.1016/j.heliyon.2023.e15112. eCollection 2023 Apr. Heliyon. 2023. PMID: 37095990 Free PMC article.
-
Thyroid Dysfunction in Periand Postmenopausal Women-Cumulative Risks.Dtsch Arztebl Int. 2023 May 5;120(18):311-316. doi: 10.3238/arztebl.m2023.0069. Dtsch Arztebl Int. 2023. PMID: 37013812 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical